Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Phenytoin sodium [antiarrythmic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
|
Product containing precisely phenytoin 50 milligram/1 each conventional release chewable tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
|
Phenytoin sodium 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
|
Phenytoin sodium 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
|
Phenytoin sodium 300 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
|
Phenytoin sodium 25 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
|
Phenytoin sodium 50 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
|
Phenytoin sodium 100mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
|
Phenytoin sodium [status epilepsy] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
|
phénytoïne sodique 50 mg/mL, ampoule de 5 mL de solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
|
Phenytoin sodium 30mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
|
Product containing precisely phenytoin sodium 100 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
|
Phenytoin sodium 50mg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
|
Product containing phenytoin sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
|
Pentobarbital sodium 390mg/phenytoin sodium 50mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
|
Pentobarbital sodium+phenytoin sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
|
Phenytoin sodium 200 mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
|
Phenytoin sodium 300 mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
|
Phenytoin sodium extended release |
Is a |
False |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
|
Phenytoin sodium prompt release |
Is a |
False |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
|
Phenytoin sodium 100mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
|
Phenytoin sodium 30mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
|
Phenytoin sodium 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
1 |
Phenytoin sodium 50 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
1 |
Phenytoin sodium 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
1 |
Phenytoin sodium 100 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
1 |
Phenytoin sodium 300 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
1 |
Phenytoin sodium 300 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
1 |
Phenytoin sodium 25 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
1 |
Phenytoin sodium 25 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
1 |
Phenytoin sodium 50 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
1 |
Phenytoin sodium 50 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely phenytoin sodium 100 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely phenytoin sodium 100 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely phenytoin sodium 100 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
1 |
Phenytoin sodium 30mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
|
Product containing precisely phenytoin sodium 100 milligram/1 each prolonged-release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely phenytoin sodium 100 milligram/1 each prolonged-release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
1 |
Phenytoin sodium 50 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
1 |
Phenytoin sodium 100 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
1 |
Phenytoin sodium 300 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
1 |
Phenytoin sodium 25 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
1 |
Phenytoin sodium 50 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely phenytoin sodium 100 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely phenytoin sodium 250 milligram/5 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely phenytoin sodium 250 milligram/5 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
1 |
Phenytoin sodium 50 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
1 |
Phenytoin sodium 50 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
1 |
Phenytoin sodium 300 mg prolonged-release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
1 |
Phenytoin sodium 300 mg prolonged-release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
1 |
Phenytoin sodium 200 mg prolonged-release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
1 |
Phenytoin sodium 200 mg prolonged-release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenytoin sodium (substance) |
Inferred relationship |
Some |
1 |